Gautam is accountable for helping shape Pfizer’s R&D strategy as well as monitoring and enhancing the value of the R&D portfolio up to Proof of Concept. He ensures rigorous asset and portfolio-level decision-making linked to the overall strategy, priorities, competitive context and financial considerations. He is responsible for key planning activities within R&D, and drives specific improvement initiatives at the Divisional and Corporate level. He is a member of Pfizer’s R&D Leadership Team and supports timely and effective dialog with key stakeholders such as the Board, CEO, analysts, shareholders and the scientific community. Prior to joining Pfizer, Gautam spent ten years at The Boston Consulting Group (BCG), a leading global strategy consulting firm. As a Senior Principal in the firm’s Healthcare Practice, Gautam worked with a host of Biotech and Pharmaceutical companies on high priority issues such as portfolio ＆ innovation strategy, R＆ D productivity, organizational redesign and post-merger integration. Gautam earned his M.B.A. from the Indian Institute of Management in Ahmedabad, India, with a focus on Strategy and Finance. He received his B.A. in Economics from St. Stephen’s College at the University of Delhi, India.